In one study on pancreatic cancer cells, SFN treatment inhibited miR-30a-3p expression, which was shown to target Cx43 and increase its expression, which led to better gemcitabine chemosensitivity (Georgikou et al., 2020). Here, GJA1 is linked to familial pancreatic carcinoma.